WilmerHale Special Counsel Dr. Peter Gey spoke on the topic "Implementing the GDPR in the field of clinical trials, pharmacovigilance," and Senior Associate Dr. Nicole Blinn spoke on the topic "Implementing the GDPR – what is left to do?"
WilmerHale Special Counsel Dr. Peter Gey spoke on the topic "Implementing the GDPR in the field of clinical trials, pharmacovigilance," and Senior Associate Dr. Nicole Blinn spoke on the topic "Implementing the GDPR – what is left to do?"
Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.
Thank you for your interest in WilmerHale.